Daniel R. Schimmel, MD, explains how balloon pulmonary angioplasty (BPA) uses balloons and specialized catheters to open narrowed vessels in the lungs to improve circulation and reduce symptoms…
Nick Norwitz interviews Aseem Malhotra, MD, a consultant cardiologist, on controversial new findings challenging LDL cholesterol’s role as an independent risk factor for heart disease. They discuss data…
NEW YORK (Reuters Health) – Of the three modalities available for treating native coarctation of the aorta, balloon angioplasty yields less favorable outcomes than surgical correction or stenting,…
NEW YORK (Reuters Health) – Delays in treatment may favor onsite fibrinolytic therapy over transfer for primary percutaneous coronary intervention (PCI) in some patients who present with ST-segment-elevation…
NEW YORK (Reuters Health) – In general, warfarin anticoagulation is beneficial in septuagenarians with atrial fibrillation, researchers report in a November 28th on-line paper in the American Journal…
NEW YORK (Reuters Health) – Exposure to thienopyridines before cardiac surgery is associated with increased risk of postop stroke, rebleeding and mortality, without any reduction in MI risk,…
NEW YORK (Reuters Health) – Contrary to expectations, left ventricular (LV) pacing is not superior to simultaneous biventricular (BiV) pacing in certain patients with symptoms of heart failure,…
NEW YORK (Reuters Health) – In patients with acute coronary syndrome (ACS) or ST-elevation myocardial infarction (STEMI), the proton pump inhibitor (PPI) esomeprazole is superior to the H2-receptor…
NEW YORK (Reuters Health) – In patients with Kawasaki disease, initial treatment with a combination of intravenous immunoglobulin (IVIG) and ulinastatin reduces the occurrence of coronary artery lesions…
NEW YORK (Reuters Health) – Treatment with the angiotensin receptor blocker (ARB) candesartan is not associated with either carcinogenesis or cancer death compared with non-ARB standard antihypertensive treatment,…
NEW YORK (Reuters Health) – In the Platelet Inhibition and Patient Outcomes (PLATO) trial, ticagrelor and clopidogrel were associated with similar rates of major bleeding, but ticagrelor was…
NEW YORK (Reuters Health) – Hospital outcomes in patients with an acute coronary syndrome are no different whether they were previously taking an angiotensin-converting enzyme inhibitor or not,…
